Themis Bioscience GmbH logo

Themis Bioscience GmbH

Themis has developed a sophisticated vaccine platform and broad pipeline based on the advanced understanding of immune system mechanisms. Initially focused on preventing infectious diseases, the Company has demonstrated the potential of its versatile platform through the rapid progression into Phase 2 clinical development for a vaccine against Chikungunya, a debilitating disease with global outbreak potential.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.themisbio.com
Founded2009
Disease Focus
Development Stage
STOCK CODENon Listed
Address
Muthgasse 11/2,1190
Vienna
Austria
Email
Contact Number
+43 1 236 7151

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/themisbio” connections=”true” suffix=””]